GlassScriptPhysician profile
Anna M Stecher
NPI 1881006005
$1,193.74
in general payments reported to CMS, 2019-2025
20 companies · $352 in 2025
The $352 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $320 · 2020: $65.62 · 2021: $82.50 · 2022: $45.56 · 2023: $62.60 · 2024: $265 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $478 · Education: $177 · Consulting Fee: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $478.20 |
| Education | $176.98 |
| Consulting Fee | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $473.35 | 2021-2025 | Veozah |
| Abbvie INC. | $169.63 | 2019-2022 | |
| Avion Pharmaceuticals | $81.63 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $55.69 | 2024-2025 | |
| Minerva Surgical, INC | $52.32 | 2019 | |
| Sage Therapeutics, LLC | $47.47 | 2024-2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $38.96 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $31.73 | 2019 | |
| Organon LLC | $30.38 | 2023-2024 | Nexplanon |
| Therapeuticsmd, INC. | $28.46 | 2019 | |
| Coopersurgical, INC. | $25.00 | 2023 | Summit Doppler |
| Pfizer INC. | $21.39 | 2025 | |
| Exeltis, USA INC. | $20.99 | 2023 | Slynd |
| Millicent US INC | $20.82 | 2025 | Femlyv |
| Amgen INC. | $20.78 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $19.64 | 2019 | |
| Gynesonics, INC. | $17.30 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Heron Therapeutics, INC. | $13.65 | 2022 | |
| Vertical Pharmaceuticals, LLC | $12.74 | 2019 | |
| Mission Pharmacal Company | $11.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Stecher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.